Stephen Young, Ph.D., D(ABMM), is a Medical Director for TriCore Research Institute’s Research and Clinical Trials Department. He is currently the principal investigator on 40 Food & Drug Administration (FDA) clinical trials, primarily for SARS-CoV-2 EUA detection assays.

Prior to becoming the Medical Director at TRI in 2015, Young was the Scientific Director of the Infectious Disease section at TriCore Reference Laboratories for 17 years. He received his B.S. and M.S. in biological sciences from Wright State University and his Ph.D. from the University of New Mexico (UNM). He completed an American Board of Medical Microbiology (ABMM) post-doctoral fellowship program at the University of Washington. Young has been a diplomat of the American Board of Medical Microbiology for the last 21 years and is a fellow of the American Association for the Advancement of Science.

Young is an emeritus professor in pathology at UNM. For 10 years he received funding from Sandia National Laboratories on the development of long-range sensors for biodefense. He has been a collaborator for 25 years in the Multi-Center AIDS Cohort Study, along with National Institutes of Health (NIH) grants affiliated with this cohort.

He is an active member of ASM and the Rio Grande Branch of ASM and served in many leadership roles in the Branch over the years.